Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-087650
Filing Date
2026-07-29
Accepted
2026-07-28 18:14:06
Documents
20
Period of Report
2026-09-15

Document Format Files

Seq Description Document Type Size
1 FORM -DEF 14A tm263608-4_def14a.htm   iXBRL DEF 14A 927967
6 GRAPHIC bc_capvsnetloss-4c.jpg GRAPHIC 58987
7 GRAPHIC bc_capvstsr-4c.jpg GRAPHIC 60060
8 GRAPHIC lg_replimuereg-4c.jpg GRAPHIC 29205
9 GRAPHIC px_26replimunepxy1pg01-4c.jpg GRAPHIC 260691
10 GRAPHIC px_26replimunepxy1pg02-4c.jpg GRAPHIC 350336
  Complete submission text file 0001104659-26-087650.txt   3640661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20260331.xsd EX-101.SCH 9877
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE repl-20260331_def.xml EX-101.DEF 2737
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20260331_lab.xml EX-101.LAB 35764
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20260331_pre.xml EX-101.PRE 5463
23 EXTRACTED XBRL INSTANCE DOCUMENT tm263608-4_def14a_htm.xml XML 204022
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38596 | Film No.: 261213192
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)